PUMA BIOTECHNOLOGY, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2024
Total Assets: $213.3M
Liabilities Breakdown FY2024
Total Liabilities: $121.2M
Asset Breakdown
Total Assets: $213.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $69.2M | 32.4% |
| Accounts Receivable | $32.0M | 15.0% |
| Inventory | $8.7M | 4.1% |
| Property, Plant & Equipment | $515.0K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $51.1M | 24.0% |
| Other Assets | $51.7M | 24.2% |
Liabilities Breakdown
Total Liabilities: $121.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.5M | 4.5% |
| Long-Term Debt | $21.7M | 17.9% |
| Other Liabilities | $94.0M | 77.5% |